HUSSMAN STRATEGIC ADVISORS, INC. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 117 filers reported holding ANI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,066,000
-3.0%
30,4000.0%0.22%
-2.2%
Q1 2021$1,099,000
+24.5%
30,4000.0%0.23%
-2.6%
Q4 2020$883,000
-11.8%
30,400
-14.4%
0.23%
-12.5%
Q3 2020$1,001,000
-12.8%
35,5000.0%0.26%
-9.6%
Q2 2020$1,148,000
-20.6%
35,5000.0%0.29%
-24.9%
Q1 2020$1,446,000
-33.9%
35,5000.0%0.39%
-44.0%
Q4 2019$2,189,000
-15.4%
35,5000.0%0.70%
-4.9%
Q3 2019$2,587,000
+25.9%
35,500
+42.0%
0.73%
+27.7%
Q2 2019$2,055,000
+115.9%
25,000
+85.2%
0.57%
+146.4%
Q1 2019$952,000
+24.4%
13,500
-20.6%
0.23%
+25.9%
Q4 2018$765,000
-20.4%
17,0000.0%0.18%
-33.5%
Q3 2018$961,00017,0000.28%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders